MORGAN STANLEY - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 78 filers reported holding REPROS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$0
-100.0%
400
-83.1%
0.00%
Q3 2017$1,0000.0%2,372
-37.4%
0.00%
Q2 2017$1,000
-97.8%
3,792
-90.0%
0.00%
Q1 2017$46,000
+21.1%
37,732
+26.8%
0.00%
Q4 2016$38,000
+65.2%
29,750
+172.4%
0.00%
Q3 2016$23,000
-17.9%
10,921
-36.7%
0.00%
Q2 2016$28,000
+33.3%
17,262
-18.8%
0.00%
Q1 2016$21,000
-40.0%
21,246
-27.6%
0.00%
Q4 2015$35,000
-99.4%
29,327
-96.0%
0.00%
-100.0%
Q3 2015$5,386,000
+106.8%
724,961
+99.0%
0.00%
+100.0%
Q2 2015$2,604,000
+39.8%
364,237
+68.0%
0.00%0.0%
Q1 2015$1,862,000
-0.9%
216,761
+15.1%
0.00%0.0%
Q4 2014$1,878,000
-42.6%
188,340
-43.0%
0.00%0.0%
Q3 2014$3,270,000
+45.5%
330,384
+154.5%
0.00%0.0%
Q2 2014$2,247,000
+437.6%
129,838
+450.3%
0.00%
Q1 2014$418,000
-15.9%
23,595
-13.1%
0.00%
Q4 2013$497,000
+59.3%
27,163
+132.8%
0.00%
Q3 2013$312,000
-17.0%
11,667
-42.8%
0.00%
Q2 2013$376,00020,3840.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders